India’s political flip-flopping over new GM field trials paralyzes innovation

In August, India’s ruling nationalist Bharatiya Janata Party (BJP) stopped its legislators from accepting Monsanto sponsorship to attend a farm exhibition in the US state of Iowa. On the surface this might seem strange: attending the Farm Progress Show should be innocuous, as Monsanto routinely takes farmers, industry experts, media and MPs from various countries to visit the show and experience for themselves the advances in agriculture.

But clearly the BJP government wants to avoid any accusations of undue influence when deciding whether India, a largely farming country of 1.2 billion people, is going to grow genetically modified (GM) food crops commercially.

Soon after the May 2014 elections, the pro-business BJP government tried to overturn India’s former environment minister, Jairam Ramesh’s, moratorium by announcing field trials for several crops, including GM aubergine. But within weeks, pressure from groups affiliated to the party, rather than from activists, pushed the government to suspend the trials and to stop legislators from accepting Monsanto’s Iowa invitation.

The government’s continued flip-flopping over field trials has disappointed Indian research scientists. Delhi University has spent 18 painstaking years developing high-yielding GM mustard only to run into bans on field trials. Its developer, Deepak Pental, says that trials with good biosafety protocols are safe and should be allowed, although he concedes that GM mustard could naturally cross with non-GM varieties, once released commercially.

So will the Indian government grasp the GM nettle? Asked this question at a public meeting in August, environment minister Prakash Javdekar remained cautious—and cryptic—saying: “We are not saying no to science. We have to take proper caution. We have to take proper action.”

Read full, original article: India Caught Between Business And Activists Over GM Crops

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claims? The evidence says mostly the opposite
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
png-pill-omega-Supp-fish-oil
Millions take omega-3 fish oil for brain health. New research suggests it may do the opposite.
ChatGPT Image May 14, 2026, 09_51_35 PM
Facebook swamped by hundreds of thousands of scam ads for illegal or dangerous medical products
ChatGPT Image May 12, 2026, 01_21_30 PM
How big health brands are funding online medical misinformation 
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT-Image-May-13-2026-12_43_37-PM-2
Longevity: Is cellular rejuvenation even possible?
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
Screenshot 2026-05-12 at 11.01
Viewpoint: Can this California pediatrician and Congressional hopeful quell anti-vaccine extremists?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.